drugset / Trial / NCT00524589

Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

NCT00524589 ↗

Phase 2 Terminated 18 enrolled Roswell Park Cancer Institute
NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Calcitriol may help prostate cancer cells become more like normal cells, and to grow and spread more slowly. Dexamethasone may help calcitriol work better by making tumor cells more sensitive to the drug. Giving calcitriol together with dexamethasone may be an effective treatment for prostate cancer that did not respond to hormone therapy . PURPOSE: This phase II trial is studying how well giving calcitriol together with dexamethasone works in treating patients with prostate cancer that did not respond to hormone therapy.

Timeline

Start
2006-04
Primary completion
2010-07
Completion
2010-09

Outcome

Outcome not reported

Stopped: “closed due to futility”

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule — Oral

Indications